Aspirin Inhibition of and#945;-Granules Release is Associated with Sirt1/AMPK and PI3K/Akt Pathway in Thrombin-Activated Platelets | OMICS International| Abstract

Cardiovascular Therapy: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Cardiovasc Ther 2016, Vol 1(2): 111

Aspirin Inhibition of α-Granules Release is Associated with Sirt1/AMPK and PI3K/Akt Pathway in Thrombin-Activated Platelets

Jie Sun1, Ming Zhang1,2, Xueqing Liu1, Xin Zhao1, Yun Jiang1, Yanyang Zhao1, Beidong Chen1 and Ruomei Qi1
1Beijing Hospital and Beijing Institute of Geriatrics, Ministry of Health, , Beijing, China
2Peking Union Medical College, , China
*Corresponding Author :

Jie Sun, Ming Zhang, Xueqing Liu, Xin Zhao,Yun Jiang, Yanyang Zhao, Beidong Chen and Ruomei Qi

Received Date: Jun 07, 2016 / Accepted Date: Jun 27, 2016 / Published Date: Jul 04, 2016


Objectives: To investigated the effect of aspirin on inhibition of platelet α-granules release in thrombin-activated platelets.
Methods: Human platelets were used in the present study. Protein expression and phosphorylation was determined by Western blot. The secreted CD40L and PF4 from platelets were detected by ELISA.
Results: Aspirin reduced CD40L and PF4 expression in thrombin-activated platelets. Sirt1 expression and AMPK phosphorylation was decreased by 24.4% and by 19.2% in thrombin-activated platelets. In contrast, aspirin dosedependently recovered Sirt1 expression and AMPK phosphorylation. EX527 (a Sirt1 inhibitor) treatment resulted in an increase in CD40L and PF4 expression. The combination of EX527 and aspirin weakened the inhibitory effect of aspirin on platelet aggregation, the expression of CD40L and PF4. Moreover, aspirin abolished the phosphorylation of Akt inthrombin-activated platelets. Aspirin has a synergistic action with LY294002 (an Akt inhibitor) on inhibition of thrombin-induced CD40L and PF4 expression.
Conclusions: Our results provide new evidence that the aspirin inhibiting platelet α-granules release not only is associated with suppressing Akt activation but also linked to activating Sirt1/AMPK pathway in thrombin-activated platelets

Keywords: Aspirin; Platelets; Sirt1; CD40 ligand; Platelet Factor 4; Thrombin

Citation: Sun J, Zhang M, Liu X, Zhao X, Jiang Y, et al. (2016) Aspirin Inhibition of α-Granules Release is Associated with Sirt1/AMPK and PI3K/Akt Pathway in Thrombin-Activated Platelets. Cardiovasc Ther 1: 111.

Copyright: © 2016 Sun J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 9954
  • [From(publication date): 6-2016 - Jul 28, 2021]
  • Breakdown by view type
  • HTML page views: 9747
  • PDF downloads: 207